INTERNATIONAL UROLOGY AND NEPHROLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2263084, encodeId=9786226308469, content=请问大家知道，这个杂志投稿过了技术筛查，想要撤稿，应该给谁发邮件消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93468626057, createdName=ms2000001911282518, createdTime=Thu May 01 19:21:36 CST 2025, time=2025-05-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1058871, encodeId=646510588e1dd, content=一个月多月了，还是editor assigned发了几次催稿都是回复模板。绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/ac8ef97af71940c7bb79f2bfcab5a58a/533d4c399d2842978a539c881715df7d.jpg, createdBy=77a92515199, createdName=董建凯, createdTime=Sat Oct 09 10:42:10 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158187, encodeId=5d25215818e6b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：7月投稿，8月大修，9月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:57:56 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2109535, encodeId=d15f210953528, content=Reviews Completed 2个月了，还没有结果，不知道是什么情况，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df368355315, createdName=ms9000001906452508, createdTime=Mon Jan 09 17:50:49 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116974, encodeId=d48d21169e490, content=请问有谁知道，我的稿件是2023.1.27录用，不知道大概等多久会通知我交版面费，版面费多少钱？什么时候收到Proof？请教各位大咖！谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56a55681531, createdName=ms5000000079061419, createdTime=Tue Feb 28 23:56:46 CST 2023, time=2023-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158188, encodeId=fae12158188e1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：不知道接收到online要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:58:37 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=556009, encodeId=fe925560097b, content=大家觉得什么时候可以突破2分呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=427, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2205947, createdName=120c55b0m22(暂无昵称), createdTime=Sat May 12 18:10:00 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102122, encodeId=a6bb210212268, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：Urology;临床 经验分享：2022年10月中旬投稿初审出奇的快，我认为还是语言的重要性有影响。4-5天。后转至under review，大概4天左右就大修了。 11月14日修回 11月22日接受总体还是挺快的。我认为语言还是挺重要的，这次和我的师兄一起合作的，还是挺顺利的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b245451535, createdName=ms1000001125368775, createdTime=Wed Nov 23 07:19:44 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577599, encodeId=89525e7599a9, content=审稿速度:3.0 经验分享：5.4 投 8.27 大修后发回 9.17小修会发回 10.1接受 修回后审稿速度就快起来了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f52438966, createdName=123cec67m91(暂无昵称), createdTime=Wed Oct 09 23:03:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143654, encodeId=107f214365410, content=请问这个杂志的审稿流程是什么，reviewers assigned是不是意思还没有审稿人，等有审稿人审稿后会出现under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Mon Jun 19 13:52:19 CST 2023, time=2023-06-19, status=1, ipAttribution=陕西省)]

2025-05-01 ms2000001911282518 来自黑龙江省

请问大家知道，这个杂志投稿过了技术筛查，想要撤稿，应该给谁发邮件消息吗

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2263084, encodeId=9786226308469, content=请问大家知道，这个杂志投稿过了技术筛查，想要撤稿，应该给谁发邮件消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93468626057, createdName=ms2000001911282518, createdTime=Thu May 01 19:21:36 CST 2025, time=2025-05-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1058871, encodeId=646510588e1dd, content=一个月多月了，还是editor assigned发了几次催稿都是回复模板。绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/ac8ef97af71940c7bb79f2bfcab5a58a/533d4c399d2842978a539c881715df7d.jpg, createdBy=77a92515199, createdName=董建凯, createdTime=Sat Oct 09 10:42:10 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158187, encodeId=5d25215818e6b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：7月投稿，8月大修，9月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:57:56 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2109535, encodeId=d15f210953528, content=Reviews Completed 2个月了，还没有结果，不知道是什么情况，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df368355315, createdName=ms9000001906452508, createdTime=Mon Jan 09 17:50:49 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116974, encodeId=d48d21169e490, content=请问有谁知道，我的稿件是2023.1.27录用，不知道大概等多久会通知我交版面费，版面费多少钱？什么时候收到Proof？请教各位大咖！谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56a55681531, createdName=ms5000000079061419, createdTime=Tue Feb 28 23:56:46 CST 2023, time=2023-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158188, encodeId=fae12158188e1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：不知道接收到online要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:58:37 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=556009, encodeId=fe925560097b, content=大家觉得什么时候可以突破2分呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=427, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2205947, createdName=120c55b0m22(暂无昵称), createdTime=Sat May 12 18:10:00 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102122, encodeId=a6bb210212268, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：Urology;临床 经验分享：2022年10月中旬投稿初审出奇的快，我认为还是语言的重要性有影响。4-5天。后转至under review，大概4天左右就大修了。 11月14日修回 11月22日接受总体还是挺快的。我认为语言还是挺重要的，这次和我的师兄一起合作的，还是挺顺利的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b245451535, createdName=ms1000001125368775, createdTime=Wed Nov 23 07:19:44 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577599, encodeId=89525e7599a9, content=审稿速度:3.0 经验分享：5.4 投 8.27 大修后发回 9.17小修会发回 10.1接受 修回后审稿速度就快起来了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f52438966, createdName=123cec67m91(暂无昵称), createdTime=Wed Oct 09 23:03:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143654, encodeId=107f214365410, content=请问这个杂志的审稿流程是什么，reviewers assigned是不是意思还没有审稿人，等有审稿人审稿后会出现under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Mon Jun 19 13:52:19 CST 2023, time=2023-06-19, status=1, ipAttribution=陕西省)]

2021-10-09 董建凯

一个月多月了，还是editor assigned发了几次催稿都是回复模板。绝了

108 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2263084, encodeId=9786226308469, content=请问大家知道，这个杂志投稿过了技术筛查，想要撤稿，应该给谁发邮件消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93468626057, createdName=ms2000001911282518, createdTime=Thu May 01 19:21:36 CST 2025, time=2025-05-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1058871, encodeId=646510588e1dd, content=一个月多月了，还是editor assigned发了几次催稿都是回复模板。绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/ac8ef97af71940c7bb79f2bfcab5a58a/533d4c399d2842978a539c881715df7d.jpg, createdBy=77a92515199, createdName=董建凯, createdTime=Sat Oct 09 10:42:10 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158187, encodeId=5d25215818e6b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：7月投稿，8月大修，9月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:57:56 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2109535, encodeId=d15f210953528, content=Reviews Completed 2个月了，还没有结果，不知道是什么情况，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df368355315, createdName=ms9000001906452508, createdTime=Mon Jan 09 17:50:49 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116974, encodeId=d48d21169e490, content=请问有谁知道，我的稿件是2023.1.27录用，不知道大概等多久会通知我交版面费，版面费多少钱？什么时候收到Proof？请教各位大咖！谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56a55681531, createdName=ms5000000079061419, createdTime=Tue Feb 28 23:56:46 CST 2023, time=2023-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158188, encodeId=fae12158188e1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：不知道接收到online要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:58:37 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=556009, encodeId=fe925560097b, content=大家觉得什么时候可以突破2分呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=427, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2205947, createdName=120c55b0m22(暂无昵称), createdTime=Sat May 12 18:10:00 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102122, encodeId=a6bb210212268, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：Urology;临床 经验分享：2022年10月中旬投稿初审出奇的快，我认为还是语言的重要性有影响。4-5天。后转至under review，大概4天左右就大修了。 11月14日修回 11月22日接受总体还是挺快的。我认为语言还是挺重要的，这次和我的师兄一起合作的，还是挺顺利的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b245451535, createdName=ms1000001125368775, createdTime=Wed Nov 23 07:19:44 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577599, encodeId=89525e7599a9, content=审稿速度:3.0 经验分享：5.4 投 8.27 大修后发回 9.17小修会发回 10.1接受 修回后审稿速度就快起来了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f52438966, createdName=123cec67m91(暂无昵称), createdTime=Wed Oct 09 23:03:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143654, encodeId=107f214365410, content=请问这个杂志的审稿流程是什么，reviewers assigned是不是意思还没有审稿人，等有审稿人审稿后会出现under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Mon Jun 19 13:52:19 CST 2023, time=2023-06-19, status=1, ipAttribution=陕西省)]

2023-09-17 ms3000000197850889 来自上海

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：嗜酸性粒细胞膀胱炎
经验分享：7月投稿，8月大修，9月

107 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2263084, encodeId=9786226308469, content=请问大家知道，这个杂志投稿过了技术筛查，想要撤稿，应该给谁发邮件消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93468626057, createdName=ms2000001911282518, createdTime=Thu May 01 19:21:36 CST 2025, time=2025-05-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1058871, encodeId=646510588e1dd, content=一个月多月了，还是editor assigned发了几次催稿都是回复模板。绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/ac8ef97af71940c7bb79f2bfcab5a58a/533d4c399d2842978a539c881715df7d.jpg, createdBy=77a92515199, createdName=董建凯, createdTime=Sat Oct 09 10:42:10 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158187, encodeId=5d25215818e6b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：7月投稿，8月大修，9月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:57:56 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2109535, encodeId=d15f210953528, content=Reviews Completed 2个月了，还没有结果，不知道是什么情况，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df368355315, createdName=ms9000001906452508, createdTime=Mon Jan 09 17:50:49 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116974, encodeId=d48d21169e490, content=请问有谁知道，我的稿件是2023.1.27录用，不知道大概等多久会通知我交版面费，版面费多少钱？什么时候收到Proof？请教各位大咖！谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56a55681531, createdName=ms5000000079061419, createdTime=Tue Feb 28 23:56:46 CST 2023, time=2023-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158188, encodeId=fae12158188e1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：不知道接收到online要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:58:37 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=556009, encodeId=fe925560097b, content=大家觉得什么时候可以突破2分呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=427, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2205947, createdName=120c55b0m22(暂无昵称), createdTime=Sat May 12 18:10:00 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102122, encodeId=a6bb210212268, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：Urology;临床 经验分享：2022年10月中旬投稿初审出奇的快，我认为还是语言的重要性有影响。4-5天。后转至under review，大概4天左右就大修了。 11月14日修回 11月22日接受总体还是挺快的。我认为语言还是挺重要的，这次和我的师兄一起合作的，还是挺顺利的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b245451535, createdName=ms1000001125368775, createdTime=Wed Nov 23 07:19:44 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577599, encodeId=89525e7599a9, content=审稿速度:3.0 经验分享：5.4 投 8.27 大修后发回 9.17小修会发回 10.1接受 修回后审稿速度就快起来了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f52438966, createdName=123cec67m91(暂无昵称), createdTime=Wed Oct 09 23:03:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143654, encodeId=107f214365410, content=请问这个杂志的审稿流程是什么，reviewers assigned是不是意思还没有审稿人，等有审稿人审稿后会出现under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Mon Jun 19 13:52:19 CST 2023, time=2023-06-19, status=1, ipAttribution=陕西省)]

2023-01-09 ms9000001906452508 来自湖北省

Reviews Completed 2个月了，还没有结果，不知道是什么情况，

102 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2263084, encodeId=9786226308469, content=请问大家知道，这个杂志投稿过了技术筛查，想要撤稿，应该给谁发邮件消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93468626057, createdName=ms2000001911282518, createdTime=Thu May 01 19:21:36 CST 2025, time=2025-05-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1058871, encodeId=646510588e1dd, content=一个月多月了，还是editor assigned发了几次催稿都是回复模板。绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/ac8ef97af71940c7bb79f2bfcab5a58a/533d4c399d2842978a539c881715df7d.jpg, createdBy=77a92515199, createdName=董建凯, createdTime=Sat Oct 09 10:42:10 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158187, encodeId=5d25215818e6b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：7月投稿，8月大修，9月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:57:56 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2109535, encodeId=d15f210953528, content=Reviews Completed 2个月了，还没有结果，不知道是什么情况，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df368355315, createdName=ms9000001906452508, createdTime=Mon Jan 09 17:50:49 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116974, encodeId=d48d21169e490, content=请问有谁知道，我的稿件是2023.1.27录用，不知道大概等多久会通知我交版面费，版面费多少钱？什么时候收到Proof？请教各位大咖！谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56a55681531, createdName=ms5000000079061419, createdTime=Tue Feb 28 23:56:46 CST 2023, time=2023-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158188, encodeId=fae12158188e1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：不知道接收到online要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:58:37 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=556009, encodeId=fe925560097b, content=大家觉得什么时候可以突破2分呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=427, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2205947, createdName=120c55b0m22(暂无昵称), createdTime=Sat May 12 18:10:00 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102122, encodeId=a6bb210212268, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：Urology;临床 经验分享：2022年10月中旬投稿初审出奇的快，我认为还是语言的重要性有影响。4-5天。后转至under review，大概4天左右就大修了。 11月14日修回 11月22日接受总体还是挺快的。我认为语言还是挺重要的，这次和我的师兄一起合作的，还是挺顺利的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b245451535, createdName=ms1000001125368775, createdTime=Wed Nov 23 07:19:44 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577599, encodeId=89525e7599a9, content=审稿速度:3.0 经验分享：5.4 投 8.27 大修后发回 9.17小修会发回 10.1接受 修回后审稿速度就快起来了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f52438966, createdName=123cec67m91(暂无昵称), createdTime=Wed Oct 09 23:03:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143654, encodeId=107f214365410, content=请问这个杂志的审稿流程是什么，reviewers assigned是不是意思还没有审稿人，等有审稿人审稿后会出现under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Mon Jun 19 13:52:19 CST 2023, time=2023-06-19, status=1, ipAttribution=陕西省)]

2023-02-28 ms5000000079061419 来自湖北省

请问有谁知道，我的稿件是2023.1.27录用，不知道大概等多久会通知我交版面费，版面费多少钱？什么时候收到Proof？请教各位大咖！谢谢！

107 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2263084, encodeId=9786226308469, content=请问大家知道，这个杂志投稿过了技术筛查，想要撤稿，应该给谁发邮件消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93468626057, createdName=ms2000001911282518, createdTime=Thu May 01 19:21:36 CST 2025, time=2025-05-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1058871, encodeId=646510588e1dd, content=一个月多月了，还是editor assigned发了几次催稿都是回复模板。绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/ac8ef97af71940c7bb79f2bfcab5a58a/533d4c399d2842978a539c881715df7d.jpg, createdBy=77a92515199, createdName=董建凯, createdTime=Sat Oct 09 10:42:10 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158187, encodeId=5d25215818e6b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：7月投稿，8月大修，9月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:57:56 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2109535, encodeId=d15f210953528, content=Reviews Completed 2个月了，还没有结果，不知道是什么情况，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df368355315, createdName=ms9000001906452508, createdTime=Mon Jan 09 17:50:49 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116974, encodeId=d48d21169e490, content=请问有谁知道，我的稿件是2023.1.27录用，不知道大概等多久会通知我交版面费，版面费多少钱？什么时候收到Proof？请教各位大咖！谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56a55681531, createdName=ms5000000079061419, createdTime=Tue Feb 28 23:56:46 CST 2023, time=2023-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158188, encodeId=fae12158188e1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：不知道接收到online要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:58:37 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=556009, encodeId=fe925560097b, content=大家觉得什么时候可以突破2分呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=427, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2205947, createdName=120c55b0m22(暂无昵称), createdTime=Sat May 12 18:10:00 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102122, encodeId=a6bb210212268, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：Urology;临床 经验分享：2022年10月中旬投稿初审出奇的快，我认为还是语言的重要性有影响。4-5天。后转至under review，大概4天左右就大修了。 11月14日修回 11月22日接受总体还是挺快的。我认为语言还是挺重要的，这次和我的师兄一起合作的，还是挺顺利的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b245451535, createdName=ms1000001125368775, createdTime=Wed Nov 23 07:19:44 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577599, encodeId=89525e7599a9, content=审稿速度:3.0 经验分享：5.4 投 8.27 大修后发回 9.17小修会发回 10.1接受 修回后审稿速度就快起来了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f52438966, createdName=123cec67m91(暂无昵称), createdTime=Wed Oct 09 23:03:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143654, encodeId=107f214365410, content=请问这个杂志的审稿流程是什么，reviewers assigned是不是意思还没有审稿人，等有审稿人审稿后会出现under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Mon Jun 19 13:52:19 CST 2023, time=2023-06-19, status=1, ipAttribution=陕西省)]

2023-09-17 ms3000000197850889 来自上海

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：嗜酸性粒细胞膀胱炎
经验分享：不知道接收到online要多久

117 0

[GetPortalCommentsPageByObjectIdResponse(id=2263084, encodeId=9786226308469, content=请问大家知道，这个杂志投稿过了技术筛查，想要撤稿，应该给谁发邮件消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93468626057, createdName=ms2000001911282518, createdTime=Thu May 01 19:21:36 CST 2025, time=2025-05-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1058871, encodeId=646510588e1dd, content=一个月多月了，还是editor assigned发了几次催稿都是回复模板。绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/ac8ef97af71940c7bb79f2bfcab5a58a/533d4c399d2842978a539c881715df7d.jpg, createdBy=77a92515199, createdName=董建凯, createdTime=Sat Oct 09 10:42:10 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158187, encodeId=5d25215818e6b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：7月投稿，8月大修，9月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:57:56 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2109535, encodeId=d15f210953528, content=Reviews Completed 2个月了，还没有结果，不知道是什么情况，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df368355315, createdName=ms9000001906452508, createdTime=Mon Jan 09 17:50:49 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116974, encodeId=d48d21169e490, content=请问有谁知道，我的稿件是2023.1.27录用，不知道大概等多久会通知我交版面费，版面费多少钱？什么时候收到Proof？请教各位大咖！谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56a55681531, createdName=ms5000000079061419, createdTime=Tue Feb 28 23:56:46 CST 2023, time=2023-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158188, encodeId=fae12158188e1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：不知道接收到online要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:58:37 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=556009, encodeId=fe925560097b, content=大家觉得什么时候可以突破2分呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=427, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2205947, createdName=120c55b0m22(暂无昵称), createdTime=Sat May 12 18:10:00 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102122, encodeId=a6bb210212268, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：Urology;临床 经验分享：2022年10月中旬投稿初审出奇的快，我认为还是语言的重要性有影响。4-5天。后转至under review，大概4天左右就大修了。 11月14日修回 11月22日接受总体还是挺快的。我认为语言还是挺重要的，这次和我的师兄一起合作的，还是挺顺利的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b245451535, createdName=ms1000001125368775, createdTime=Wed Nov 23 07:19:44 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577599, encodeId=89525e7599a9, content=审稿速度:3.0 经验分享：5.4 投 8.27 大修后发回 9.17小修会发回 10.1接受 修回后审稿速度就快起来了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f52438966, createdName=123cec67m91(暂无昵称), createdTime=Wed Oct 09 23:03:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143654, encodeId=107f214365410, content=请问这个杂志的审稿流程是什么，reviewers assigned是不是意思还没有审稿人，等有审稿人审稿后会出现under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Mon Jun 19 13:52:19 CST 2023, time=2023-06-19, status=1, ipAttribution=陕西省)]

2018-05-12 120c55b0m22(暂无昵称)

大家觉得什么时候可以突破2分呢。

427 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2263084, encodeId=9786226308469, content=请问大家知道，这个杂志投稿过了技术筛查，想要撤稿，应该给谁发邮件消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93468626057, createdName=ms2000001911282518, createdTime=Thu May 01 19:21:36 CST 2025, time=2025-05-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1058871, encodeId=646510588e1dd, content=一个月多月了，还是editor assigned发了几次催稿都是回复模板。绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/ac8ef97af71940c7bb79f2bfcab5a58a/533d4c399d2842978a539c881715df7d.jpg, createdBy=77a92515199, createdName=董建凯, createdTime=Sat Oct 09 10:42:10 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158187, encodeId=5d25215818e6b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：7月投稿，8月大修，9月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:57:56 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2109535, encodeId=d15f210953528, content=Reviews Completed 2个月了，还没有结果，不知道是什么情况，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df368355315, createdName=ms9000001906452508, createdTime=Mon Jan 09 17:50:49 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116974, encodeId=d48d21169e490, content=请问有谁知道，我的稿件是2023.1.27录用，不知道大概等多久会通知我交版面费，版面费多少钱？什么时候收到Proof？请教各位大咖！谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56a55681531, createdName=ms5000000079061419, createdTime=Tue Feb 28 23:56:46 CST 2023, time=2023-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158188, encodeId=fae12158188e1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：不知道接收到online要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:58:37 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=556009, encodeId=fe925560097b, content=大家觉得什么时候可以突破2分呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=427, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2205947, createdName=120c55b0m22(暂无昵称), createdTime=Sat May 12 18:10:00 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102122, encodeId=a6bb210212268, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：Urology;临床 经验分享：2022年10月中旬投稿初审出奇的快，我认为还是语言的重要性有影响。4-5天。后转至under review，大概4天左右就大修了。 11月14日修回 11月22日接受总体还是挺快的。我认为语言还是挺重要的，这次和我的师兄一起合作的，还是挺顺利的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b245451535, createdName=ms1000001125368775, createdTime=Wed Nov 23 07:19:44 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577599, encodeId=89525e7599a9, content=审稿速度:3.0 经验分享：5.4 投 8.27 大修后发回 9.17小修会发回 10.1接受 修回后审稿速度就快起来了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f52438966, createdName=123cec67m91(暂无昵称), createdTime=Wed Oct 09 23:03:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143654, encodeId=107f214365410, content=请问这个杂志的审稿流程是什么，reviewers assigned是不是意思还没有审稿人，等有审稿人审稿后会出现under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Mon Jun 19 13:52:19 CST 2023, time=2023-06-19, status=1, ipAttribution=陕西省)]

2022-11-23 ms1000001125368775

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：Urology;临床
经验分享：2022年10月中旬投稿初审出奇的快，我认为还是语言的重要性有影响。4-5天。后转至under review，大概4天左右就大修了。 11月14日修回 11月22日接受总体还是挺快的。我认为语言还是挺重要的，这次和我的师兄一起合作的，还是挺顺利的

151 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2263084, encodeId=9786226308469, content=请问大家知道，这个杂志投稿过了技术筛查，想要撤稿，应该给谁发邮件消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93468626057, createdName=ms2000001911282518, createdTime=Thu May 01 19:21:36 CST 2025, time=2025-05-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1058871, encodeId=646510588e1dd, content=一个月多月了，还是editor assigned发了几次催稿都是回复模板。绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/ac8ef97af71940c7bb79f2bfcab5a58a/533d4c399d2842978a539c881715df7d.jpg, createdBy=77a92515199, createdName=董建凯, createdTime=Sat Oct 09 10:42:10 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158187, encodeId=5d25215818e6b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：7月投稿，8月大修，9月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:57:56 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2109535, encodeId=d15f210953528, content=Reviews Completed 2个月了，还没有结果，不知道是什么情况，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df368355315, createdName=ms9000001906452508, createdTime=Mon Jan 09 17:50:49 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116974, encodeId=d48d21169e490, content=请问有谁知道，我的稿件是2023.1.27录用，不知道大概等多久会通知我交版面费，版面费多少钱？什么时候收到Proof？请教各位大咖！谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56a55681531, createdName=ms5000000079061419, createdTime=Tue Feb 28 23:56:46 CST 2023, time=2023-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158188, encodeId=fae12158188e1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：不知道接收到online要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:58:37 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=556009, encodeId=fe925560097b, content=大家觉得什么时候可以突破2分呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=427, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2205947, createdName=120c55b0m22(暂无昵称), createdTime=Sat May 12 18:10:00 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102122, encodeId=a6bb210212268, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：Urology;临床 经验分享：2022年10月中旬投稿初审出奇的快，我认为还是语言的重要性有影响。4-5天。后转至under review，大概4天左右就大修了。 11月14日修回 11月22日接受总体还是挺快的。我认为语言还是挺重要的，这次和我的师兄一起合作的，还是挺顺利的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b245451535, createdName=ms1000001125368775, createdTime=Wed Nov 23 07:19:44 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577599, encodeId=89525e7599a9, content=审稿速度:3.0 经验分享：5.4 投 8.27 大修后发回 9.17小修会发回 10.1接受 修回后审稿速度就快起来了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f52438966, createdName=123cec67m91(暂无昵称), createdTime=Wed Oct 09 23:03:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143654, encodeId=107f214365410, content=请问这个杂志的审稿流程是什么，reviewers assigned是不是意思还没有审稿人，等有审稿人审稿后会出现under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Mon Jun 19 13:52:19 CST 2023, time=2023-06-19, status=1, ipAttribution=陕西省)]

2019-10-09 123cec67m91(暂无昵称)

审稿速度:3.0
经验分享：5.4 投
8.27 大修后发回
9.17小修会发回
10.1接受
修回后审稿速度就快起来了

285 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2263084, encodeId=9786226308469, content=请问大家知道，这个杂志投稿过了技术筛查，想要撤稿，应该给谁发邮件消息吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93468626057, createdName=ms2000001911282518, createdTime=Thu May 01 19:21:36 CST 2025, time=2025-05-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1058871, encodeId=646510588e1dd, content=一个月多月了，还是editor assigned发了几次催稿都是回复模板。绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210905/ac8ef97af71940c7bb79f2bfcab5a58a/533d4c399d2842978a539c881715df7d.jpg, createdBy=77a92515199, createdName=董建凯, createdTime=Sat Oct 09 10:42:10 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158187, encodeId=5d25215818e6b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：7月投稿，8月大修，9月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:57:56 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2109535, encodeId=d15f210953528, content=Reviews Completed 2个月了，还没有结果，不知道是什么情况，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df368355315, createdName=ms9000001906452508, createdTime=Mon Jan 09 17:50:49 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116974, encodeId=d48d21169e490, content=请问有谁知道，我的稿件是2023.1.27录用，不知道大概等多久会通知我交版面费，版面费多少钱？什么时候收到Proof？请教各位大咖！谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56a55681531, createdName=ms5000000079061419, createdTime=Tue Feb 28 23:56:46 CST 2023, time=2023-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2158188, encodeId=fae12158188e1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：嗜酸性粒细胞膀胱炎 经验分享：不知道接收到online要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8465528739, createdName=ms3000000197850889, createdTime=Sun Sep 17 21:58:37 CST 2023, time=2023-09-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=556009, encodeId=fe925560097b, content=大家觉得什么时候可以突破2分呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=427, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2205947, createdName=120c55b0m22(暂无昵称), createdTime=Sat May 12 18:10:00 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102122, encodeId=a6bb210212268, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：Urology;临床 经验分享：2022年10月中旬投稿初审出奇的快，我认为还是语言的重要性有影响。4-5天。后转至under review，大概4天左右就大修了。 11月14日修回 11月22日接受总体还是挺快的。我认为语言还是挺重要的，这次和我的师兄一起合作的，还是挺顺利的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b245451535, createdName=ms1000001125368775, createdTime=Wed Nov 23 07:19:44 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577599, encodeId=89525e7599a9, content=审稿速度:3.0 经验分享：5.4 投 8.27 大修后发回 9.17小修会发回 10.1接受 修回后审稿速度就快起来了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f52438966, createdName=123cec67m91(暂无昵称), createdTime=Wed Oct 09 23:03:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143654, encodeId=107f214365410, content=请问这个杂志的审稿流程是什么，reviewers assigned是不是意思还没有审稿人，等有审稿人审稿后会出现under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Mon Jun 19 13:52:19 CST 2023, time=2023-06-19, status=1, ipAttribution=陕西省)]

2023-06-19 ms4000001680328946 来自陕西省

请问这个杂志的审稿流程是什么，reviewers assigned是不是意思还没有审稿人，等有审稿人审稿后会出现under review吗

128 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务